Our staff and collaborators have authored 300+ papers over many years.
Using established practices and published methods, in dedicated synthetic facilities. Whilst also providing end material analysis via NMR, MS and other specialist techniques.
Including but not limited to:
By using novel lipid antigens we have been able to develop assays for specific mycobacterial diseases.
Expertise in research and development of assays for:
Alongside our core technology we are also capable of producing many other compounds found in mycobacteria.
Diagnostig was spun out of Bangor University as a Point of Care diagnostics company, and our class 2 biological facility allows us to develop these capabilities based on our ELISA assays.